Provision of written informed consent to participate in the study by the patient or his/her legally authorized representative after receiving and understanding a detailed explanation of the study
Adults aged 70 years or older
Diagnosed with type 2 diabetes or currently receiving antidiabetic medication, without a history or presence of cardiovascular disease
Either: (1) LDL-C≥100 mg/dL if not receiving lipid-lowering therapy, or (2) currently receiving lipid-lowering therapy (in this case, LDL-C level not restricted)
Contraindications to study drugs
Pregnant or breastfeeding women
You may not be if
Diagnosis of type 1 diabetes
Documented history of atherosclerotic cardiovascular disease at screening, confirmed clinically or by imaging: (1) myocardial infarction; (2) coronary revascularization; (3) currently receiving treatment for acute coronary syndrome; (4) history of ischemic stroke; (5) aortic aneurysm; (6) peripheral arterial disease
Currently undergoing cancer treatment
Severe disease requiring recurrent hospitalization
Frailty (defined as a score ≥3 on the Korean FRAIL questionnaire), or any condition significantly limiting self-care